Please login to the form below

Not currently logged in
Email:
Password:

acquisitions

This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

Shire warms to Takeda’s latest offer, extending deadline

Shire warms to Takeda’s latest offer, extending deadline

Takeda’s share price has continued its recent slide after the latest announcement, reflecting investor uncertainty about the plan, and analysts continued to voice their concerns that the acquisition could be

Latest news

More from news
Approximately 174 fully matching, plus 1,023 partially matching documents found.

Latest Intelligence

  • When is it time to rebrand? When is it time to rebrand?

    We need new brand architecture to deal with acquisitions. We need to create an online equivalent of our offline experience. ... industry leader. We need a new name. We need to evaluate our acquisition’s brand and fold it into our.

  • Deal Watch January 2018

    Portfolio/pipeline in haemophilia and other rare blood disorders. Acquisition company. 11, 600. ... This acquisition brings tucatinib, an oral tyrosine kinase inhibitor that is highly selective for HER2.

  • Digital

    Healthcare terms - Digital.

  • Marketing

    Healthcare terms - Marketing.

  • Drug pricing

    Healthcare terms - Drug pricing.

More from intelligence
Approximately 73 fully matching, plus 73 partially matching documents found.

Latest appointments

  • Smith & Nephew name new CEO Smith & Nephew name new CEO

    Nawana has joined Smith &Nephew from medical diagnostics company Alere, where he was also chief executive officer, and oversaw its $5.3bn acquisition by Abbott last year.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Previously, Mullen has served as chief executive officer of Patheon, a pharmaceutical development and manufacturing services provider, until its acquisition by Thermo Fisher Scientific last year.

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    acquisition of drug candidates, commercial products and companies for the global speciality drug business. ... With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy,

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    Mere weeks after completing its acquisition of CAR-T specialist Juno, Celgene has added to its cell therapy pipeline with another clinical-stage CAR-T candidate from Bluebird Bio. ... The firmed-up deal with Bluebird comes after Celgene completed its

  • Juno Therapeutics names Cindy Elkins as CIO Juno Therapeutics names Cindy Elkins as CIO

    Elkins most recently served as vice president, IT for the Americas at Genentech, where she led its US commercial technology integration following the firm's acquisition by Roche.

More from appointments
Approximately 0 fully matching, plus 113 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 47 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics